Join our Stem Cell Recruitment Therapy® Program. Join Now

News
All News Recent News Uncategorized

Russell Health Honored in Global Business Leaders Magazine’s “20 Leading Companies of the Year 2021.”

Willowbrook, IL, Monday, April 12, 2021- Based in Willowbrook, Illinois, Russell Health is a national marketer and distributor of specialty medical products and services. Russell Health, Inc., was recently awarded as #2 in Global Business Leaders Magazine’s “20 Leading Companies of the Year 2021.” Based in Atlanta, Georgia, Global Business Leaders Magazine’s mission ‘focuses on…

Keep Reading

Russell Health Highlighted in The Silicon Review’s “50 Leading Companies of the Year 2021”

Willowbrook, IL, Wednesday, March 31, 2021- Based in Willowbrook, Illinois, Russell Health, a national marketer and distributor of specialty medical products and services. Russell Health was recently announced as one of The Silicon Review's “50 Leading Companies of the Year 2021." The feature strategically places the Russell Health brand alongside other tech innovators in industries…

Keep Reading

Overview: Effectiveness of Amniotic Fluid Injection In The Treatment of Trigger Finger

In a recent study published by the Journal of Hand Surgery Global Online, the efficacy and safety of treating trigger finger with amniotic fluid therapy was assessed. All participants had 1mL of amniotic fluid injected into the tendon sheath. Patients were followed for an average of 11 months with a pain score (0-10) decrease from…

Keep Reading

Overview: Effectiveness of Epidural Amniotic Fluid Injection for Low Back Pain

A recent article published in September of 2020 by The Spine Journal features a pilot study that gives great hope to patients suffering from spinal pain. The patients included in the study were diagnosed with HNP (herniated nucleus pulposus), DDD (degenerative disc disease) or spinal stenosis. Their lower back pain and leg pain had persisted for…

Keep Reading

Russell Health’s Stem Cell Recruitment Therapy® & Stem Cell Recruitment Facial® Trademark Registrations Approved by USPTO

Russell Health, Inc, a leading regenerative medicine company, announced today the United States Patent and Trademark Office has issued registrations  for the company’s trademarks - Stem Cell Recruitment Therapy® (Reg. No. 6,109,514) and Stem Cell Recruitment Facial® (Reg. No. 6,218,705), signifying that the company has met the stringent United States standards for exclusively applying its…

Keep Reading

Russell Health Recognized as One of The “10 Most Promising Biotech Startups 2020”

StartUp City Magazine recognizes Russell Health, Inc. as one of the "10 Most Promising Biotech Startup 2020". With Russell Health's innovative regenerative medicine product lines, StartUp City Magazine recognizes Russell Health for its relentless pursuit of safe, effective and innovative regenerative medicine products. Recipients of this honor are decided by a distinguished panel of biotechnology…

Keep Reading

Amniotic fluid May Provide a Ground Breaking Treatment for Ischemic Stroke

According to a study released in STEM CELLS Translational Medicine, this is a possible new way of treatment for ischemitc stroke. Ischemitc stroke occurs when a vessel supplying blood to the brain is blocked by fatty plaque within the blood vessel. According to World Stroke Organization, it accounts for about 87% of all strokes and…

Keep Reading

Ocular Amniotic Membrane Success Stories by Dr. Stephanie Woo

Dr. Stephanie Woo, O.D. is the only cornea/contact lens residency-trained doctor of optometry for 200 miles in her hometown of Lake Havasu City, AZ. A patient presented to her office with an elevated lesion on her cornea. The patient did not respond to antibiotics, antivirals, or steroids. Unable to travel to another specialist, Dr. Woo decided…

Keep Reading

Medicare to Cover All FDA-approved Covid-19 Vaccines

The Centers for Medicare and Medicaid Services released an interim final rule yesterday (10/28) stating that Medicare will cover vaccines that receive FDA authorization. This includes vaccines that receive emergency use authorization, at no cost to beneficiaries. There is an international race between drug development companies to create a safe Covid-19 vaccine. Previously reported by…

Keep Reading